Literature DB >> 30586155

A Patient-Centered Approach to Comparative Effectiveness Research Focused on Older Adults: Lessons From the Patient-Centered Outcomes Research Institute.

Noah R Mason1, Harold C Sox1, Evelyn P Whitlock1.   

Abstract

The mission of the Patient-Centered Outcomes Research Institute (PCORI) is to fund the production of high-quality evidence that will enable patients and clinicians to make informed, personalized healthcare decisions. Since 2012, the PCORI has invested $177 million in patient-centered comparative effectiveness research (CER) that specifically targets the health needs of older adults, with additional relevant studies in its broader portfolio. Developing the PCORI's research portfolio has provided us with significant insights into what factors to consider when conducting CER in older adult populations. When comparing the net benefit of two or more interventions for older adults, investigators should consider the following: absolute risk difference, competing risks, life expectancy, the difference between chronologic and physiologic age, the importance of patient preferences, and other potential drivers of variable treatment effects. Investigators should also engage older adults and their caregivers as partners throughout the research process. Their input helps to identify key outcomes of interest and insights about the conduct of the research. As the PCORI continues to support research that addresses the healthcare decisions of the rapidly growing older adult population, it needs to partner with patients and researchers to identify the most important questions to address. J Am Geriatr Soc 67:21-28, 2019.
© 2018 The Authors. Journal of the American Geriatrics Society published by Wiley Periodicals, Inc. on behalf of The American Geriatrics Society.

Entities:  

Keywords:  comparative effectiveness research; geriatrics; older adults; patient-centered outcomes research; treatment response heterogeneity

Mesh:

Year:  2018        PMID: 30586155     DOI: 10.1111/jgs.15655

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  7 in total

1.  Engagement, Exploitation, and Human Intracranial Electrophysiology Research.

Authors:  Michelle T Pham; Nader Pouratian; Ashley Feinsinger
Journal:  Neuroethics       Date:  2022-08-13       Impact factor: 1.427

2.  Engagement of older adults with multimorbidity as patient research partners: Lessons from a patient-oriented research program.

Authors:  Maureen Markle-Reid; Rebecca Ganann; Jenny Ploeg; Gail Heald-Taylor; Laurie Kennedy; C McAiney; Ruta Valaitis
Journal:  J Multimorb Comorb       Date:  2021-03-17

Review 3.  Providing Medical Information to Older Adults in a Web-Based Environment: Systematic Review.

Authors:  Bianca McLean; Nazia Hossain; Valentina Donison; Mikaela Gray; Sara Durbano; Kristen Haase; Shabbir Muhammad Husayn Alibhai; Martine Puts
Journal:  JMIR Aging       Date:  2021-02-09

Review 4.  Challenges in Geriatric Oncology-A Surgeon's Perspective.

Authors:  Ruth Parks; Kwok-Leung Cheung
Journal:  Curr Oncol       Date:  2022-01-29       Impact factor: 3.677

5.  [Quality assurance follow-up survey of the ELISA cohort study on COVID-19 prevalence: The view of study participants - What is well received?]

Authors:  Elke Peters; Aiham Alabid; Susanne Elsner; Christine Klein; Max Borsche; Jan Rupp; Alexander Katalinic
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2022-08-25

6.  Attitudes of Homebound Older Adults and Their Caregivers Toward Research and Participation as Research Advisors.

Authors:  Ashley L Eaton England; Christine S Ritchie; Alexandria Mickler; Carla M Perissinotto; Sarah K Garrigues; Bruce Leff; Orla C Sheehan; Krista L Harrison
Journal:  Gerontologist       Date:  2021-11-15

7.  Predicting Risk of Atherosclerotic Cardiovascular Disease Using Pooled Cohort Equations in Older Adults With Frailty, Multimorbidity, and Competing Risks.

Authors:  Quoc Dinh Nguyen; Michelle C Odden; Carmen A Peralta; Dae Hyun Kim
Journal:  J Am Heart Assoc       Date:  2020-09-02       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.